HEALA Stock Overview
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.06 |
| 52 Week High | US$6.06 |
| 52 Week Low | US$6.06 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | -1.13% |
| 1 Year Change | -11.85% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -12.96% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HEALA | GB Capital Markets | GB Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 2.0% |
| 1Y | -11.9% | 10.7% | 4.5% |
Return vs Industry: HEALA underperformed the UK Capital Markets industry which returned 5.2% over the past year.
Return vs Market: HEALA underperformed the UK Market which returned -3.9% over the past year.
Price Volatility
| HEALA volatility | |
|---|---|
| HEALA Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: HEALA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HEALA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | n/a | www.ishares.com/uk/institutional/en/products/284216/HEAL |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe.
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Fundamentals Summary
| HEALA fundamental statistics | |
|---|---|
| Market cap | €1.06b |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs HEALA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEALA income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HEALA perform over the long term?
See historical performance and comparison